Tumour necrosis factor-alpha cytokine promoter gene polymorphism in Hodgkin's disease and chronic lymphocytic leukaemia.

Autor: Wihlborg C; Department of Haematology and Infectious Diseases, Radiumhemmet, Karolinska Hospital, Stockholm, Sweden., Sjöberg J, Intaglietta M, Axdorph U, Pisa EK, Pisa P
Jazyk: angličtina
Zdroj: British journal of haematology [Br J Haematol] 1999 Feb; Vol. 104 (2), pp. 346-9.
DOI: 10.1046/j.1365-2141.1999.01176.x
Abstrakt: Regulation of cytokine levels has been shown to be under genetic control through the coding and promoter sequences of genetic polymorphisms. We elucidated the prevalence of a previously described G to A transition polymorphism at position -308 of the tumour necrosis factor-alpha (TNF-alpha) promoter region in a population of patients with Hodgkin's disease (HD) (n = 36) and chronic lymphocytic leukaemia (CLL) (n = 49) and healthy volunteers (n = 51). The DNA fragment containing this polymorphism was amplified by PCR and sequenced by solid-phase minisequencing. The frequency of the TNF-alpha promoter polymorphism was not significantly different between CLL patients and HD patients compared to controls.
Databáze: MEDLINE